Amniotics AB (OSTO:AMNI) Total Equity : kr15.54 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Total Equity?

Amniotics AB's total equity for the quarter that ended in Dec. 2023 was kr15.54 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Amniotics AB Total Equity Historical Data

The historical data trend for Amniotics AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Total Equity Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

12.91

42.19

49.53

1.48

15.54

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Total Equity	Get a 7-Day Free Trial										11.42	1.48	9.02	2.36	15.54

Amniotics AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Amniotics AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	26.086	-	10.547
	=	15.54

Amniotics AB's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	26.086	-	10.547
	=	15.54

Amniotics AB Total Equity Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.